Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on June 9, 2014. The filing discloses two primary corporate events: a solicitation of consents to amend the indenture for its 12.875% senior notes due 2018, and the execution of an agreement to acquire Partnerships in Care Investments 1 Limited (the "Target") and related property assets.
Key Financial Metrics and Transaction Details
- Debt Restructuring: Acadia is seeking to amend its 12.875% senior notes to increase the permitted secured leverage ratio, enabling the incurrence of additional secured indebtedness.
- Acquisition Agreement: On June 3, 2014, a wholly-owned subsidiary of Acadia entered into an agreement to purchase all ordinary shares of Partnerships in Care Investments 1 Limited and specific property shares from Partnerships in Care Holdings Limited and The Royal Bank of Scotland plc.
- Closing Date: The transaction is scheduled to close on July 1, 2014.
- Financial Statements: The filing includes unaudited pro forma condensed combined financial information for Acadia and the Target as of March 31, 2014, and for the fiscal year ended December 31, 2013. It also includes audited combined financial statements for the Target prepared under UK GAAP.
Material Changes and Disclosures
The filing does not provide specific numerical values for revenue, profit, or cash flow within the text of the report itself; these figures are contained in the attached exhibits (Exhibit 99.2 and 99.3). The material change disclosed is the strategic shift to acquire UK-based healthcare assets and the concurrent modification of debt covenants to facilitate this expansion. The filing notes that the Target's financial statements are prepared under UK GAAP and have not been reconciled to US GAAP, except where noted in the exhibits.
Outlook, Risks, and Management Commentary
Management states the purpose of the debt amendment is to afford "greater financial flexibility." The filing includes updated Risk Factors (Exhibit 99.4) reflecting the new transaction. The report contains forward-looking statements regarding the expected closing of the transaction and future performance, which are subject to risks and uncertainties. Acadia explicitly disclaims any obligation to update these forward-looking statements.
Investor Verification Checklist
- Verify the specific financial impact of the acquisition by reviewing the Unaudited Pro Forma Condensed Combined Financial Information in Exhibit 99.2.
- Review the audited combined financial statements of the Target in Exhibit 99.3 to understand the UK GAAP basis and any noted reconciliations to US GAAP.
- Examine the updated Risk Factors in Exhibit 99.4 for new liabilities or operational risks associated with the UK acquisition.
- Confirm the terms of the indenture amendment regarding the "Permitted Liens" and secured leverage ratio in the press release (Exhibit 99.1).
- Monitor the July 1, 2014 closing date for the transaction to ensure timely completion.